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Introduction: Acute Kidney Injury (AKI) is common in Critical Care patient and cause 
significant increase mortality and morbidity. Early management of Renal Replacement Therapy 
with correct dose and suitable modality is an essential intervention in severe AKI. Hybrid 
therapy like Sustained Low Efficiency Daily Dialysis (SLEDD) has emerged as an alternative to 
CRRT in Intensive Care Unit (ICU) patients. Sustained Low Efficiency Daily Diafiltration 
(SLEDD-f), which contains both diffusion and convection principles, also suggested to provides 
stable renal replacement therapy. Thus, we formulated this study to compare the outcome 
between the administration of SLEDD and SLEDD-f in Critical Care patient with Acute Kidney 
Injury. 
   
Objectives: The objective of this randomized control trial is to compare the Intensive 
Care Unit (ICU) Survival between SLEDD and SLEDD-f in Critical Care patient with Acute 
Kidney Injury. The specific objective is to compare Length of Stay in ICU and Hospital, Days of 
Ventilatory support, as well as control of acid base balance, small solute (urea and creatinine) 
and electrolytes (sodium and potassium) between SLEDD and SLEDD-f.   
 
Methods: Fourteen patient, with Acute Kidney Injury in Critical Care were selected with 
selection criteria were randomized into two group to received either Sustained Low Efficiency 
Daily Dialysis (SLEDD) or Sustained Low Efficiency Daily Diafiltration (SLEDD-f) for Renal 
Replacement Therapy. Selected parameters and blood investigation were recorded and compared 
including ICU predicted score, acid base status, renal function test, urine output and electrolytes 
are all taken during admission to hospital and critical care, before initiating the dialysis, day one 
after starting the dialysis until discharged from critical care and hospital, as well as during follow 
up until 42 days after dialysis. 3 month mortality also been recorded. 
 
Results: In both SLEDD and SLEDD-f group, the distributions of social-demographic, 
medical background status, as well as ICU predicted mortality like SOFA, SAPS II and 
APACHE II were similar. 85.7% of the AKI was due to sepsis while 14.3% due to multifactorial 
cause. Overall, there is no significant differences of outcome distribution (ICU and hospital 
survival, length of ICU and hospital stay; and duration of ventilatory support) and parameter 
distribution (urea, creatinine, sodium, pottasium and acid base balance) between patients 
receiving SLEDD and SLEDD-f technique (p>0.05). Mortality rate at day 60 reveals no 
significant difference in between both modalities with SLEDD having 42.9% mortality and 
SLEDD-f 14.3 % (p=0.554). In general, patients in SLEDD-f group have a shorter duration of 
ICU stay (median, 11 days [IQR 5 to 37 days]), duration of ventilation (median, 5 days [IQR 4 to 
33 days]) and have a higher ICU survival (85.7%) compare to SLEDD group, but this was not 
statistically significant. Meanwhile, SLEDD have a shorter duration of hospital stay (median, 25 
days [IQR 16 to 29 days]) and this may result from higher mortality compare to SLEDD-f as the 
survivor may have prolonged length of stay at hospital.  
 
Conclusion: The administrations of SLEDD and SLEDD-f in ICU patients with AKI are 
feasible and comparable in terms of ICU survival, Length of ICU stay, Days of Ventilatory 
support as well as control of small solutes, electrolytes and acid base balance. Therefore, 
SLEDD-f can be used as an alternative therapy other than the conventional SLEDD with shorter 
duration of 4 hours as compared to SLEDD of 6 hours. 
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ABSTRAK 
 
Tajuk: Kajian Kawalan Pilot Secara Rambang membandingkan hasil Sustained Low 
Efficiency Daily Dialysis (SLEDD) dengan Sustained Low Efficiency Daily Diafiltration 
(SLEDD-f) di kalangan pesakit yang mengalami kegagalan buah pinggang akut (AKI) di wad 
rawatan rapi. 
 
Latar Belakang: Kecederaan buah pinggang akut (AKI) kerap berlaku di kalangan pesakit di 
wad rawatan rapi dan menyebabkan peningkatan kadar kematian dan morbiditi yang ketara. 
Rawatan awal Terapi Penggantian Buah pinggang (RRT) dengan modaliti dan dos yang 
bersesuaian adalah rawatan sokongan yang  penting bagi pesakit yang mengalami AKI yang 
teruk. Terapi hibrid seperti Sokongan Dialisis Harian Kecekapan Rendah Berterusan (SLEDD) 
telah muncul sebagai alternatif kepada CRRT untuk  pesakit di unit rawatan rapi (ICU). 
Manakala Sokongan Diafiltrasi Harian Kecekapan Rendah Berterusan (SLEDD-f), yang 
mengandungi kedua-dua prinsip difusi dan konveksi, turut dikatakan sebagai menyediakan 
rawatan penggantian buah pinggang yang stabil. Oleh itu, kami menjalankan  kajian ini untuk 
membandingkan hasil diantara rawatan  SLEDD dan SLEDD-f di kalangan pesakit unit 
rawatan rapi yang mengalami AKI. 
   
  
xv 
 
Objektif: Objektif umum kajian pilot rawak kawalan ini adalah untuk membandingkan 
survival ICU diantara SLEDD dan SLEDD-f di dalam rawatan pesakit kritikal dengan AKI. 
Objektif khusus pula adalah untuk membandingkan  di tempoh masa di ICU dan 
Hospital,tempoh  sokongan ventilasi, serta imbangan asid base, kestabilan garam larut (urea 
dan creatinine) dan elektrolit (sodium dan pottasium) diantara SLEDD dan SLEDD-f. 
 
Kaedah: Empat belas pesakit, dengan kecederaan buah pinggang akut didalam Wad Rawatan 
Kritikal, dipilih melalui kriteria pemilihan yang ditetapkan telah dibahagikan secara rambang 
kepada dua kumpulan untuk menerima samada  SLEDD atau SLEDD-f sebagai rawatan 
Penggantian Buah pinggang. Parameter tertentu dan penyiasatan darah direkodkan dan 
dibandingkan termasuk skor ICU (APACHE II, SAPS II dan SOFA), status imbangan asid-
base, ujian fungsi renal, elektrolit semuanya direkod dan dibandingkan semasa kemasukan ke 
hospital, wad rawatan rapi ICU, sebelum memulakan dialisis, hari pertama dialisis sehingga 
keluar dari unit rawatan rapi dan hospital, serta semasa susulan sehingga hari ke 42. Kematian 
pada hari ke 60 dan bulan ketiga juga direkodkan.  
 
Hasil: Dalam kedua-dua kumpulan SLEDD dan SLEDD-f, taburan status demografi sosial dan 
latar belakang perubatan, serta skor ICU adalah sama. 85.7% pesakit AKI adalah disebabkan 
oleh sepsis manakala 14.3% disebabkan oleh punca multifaktorial lain Secara keseluruhan, 
tidak ada perbezaan yang signifikan di dalam taburan hasil (Survival ICU dan hospital, tempoh 
masa di ICU dan hospital, serta tempoh sokongan ventilasi) dan taburan parameter yang dikaji 
(urea, creatinine, sodium, potasium dan imbangan asid-base) di antara pesakit yang menerima 
rawatan SLEDD dan SLEDD-f (p> 0.05). . Kadar kematian keseluruhan pada hari ke 60 atas 
sebarang sebab menunjukkan tiada perbezaan signifikan diantara kedua-dua kumpulan dengan 
xvi 
 
SLEDD 42.9% dan SLEDD-f 14.3%. Umumnya pesakit dalam kumpulan SLEDD-f 
mempunyai tempoh masa yang lebih pendek di ICU(median, 11 hari [IQR 5-37 hari]), tempoh 
sokongan ventilasi (median, 5 hari [IQR 4-33 hari] ) dan survival ICU yang lebih tinggi 
(85.7%) berbanding dengan kumpulan SLEDD, tetapi ini tidak signifikan secara statistik. 
Sementara itu, SLEDD mempunyai tempoh masa di hospital yang lebih rendah (median, 25 
hari [IQR 16-29 hari]) dan ini boleh disebabkan kadar mortaliti yang lebih tinggi (42.9%) 
berbanding dengan SLEDD-f, Ini mungkin disebabkan mereka yang hidup terus tinggal lama di 
dalam hospital. 
  
Kesimpulan: Rawatan SLEDD dan SLEDD-f dikalangan pesakit ICU dengan AKI adalah 
boleh dijalankan dan setanding dari segi survival ICU dan hospital, tempoh masa di ICU dan 
hospital, tempoh sokongan ventilasi, serta kawalan elektrolit (sodium dan potasium), bahan 
larut (urea dan creatinine) dan imbangan asid-base. Oleh itu, SLEDD-f boleh digunakan 
sebagai terapi alternatif pesakit AKI selain rawatan konvensional SLEDD, dengan tempoh 4 
jam yang lebih ringkas dengan diffusi dan konveksi berbanding 6 jam SLEDD.   
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ABSTRACT 
 
Title: A Pilot Randomized Controlled Trial Comparing the Outcome of Sustained Low 
Efficiency Daily Dialysis (SLEDD) with Sustained Low Efficiency Daily Diafiltration 
(SLEDD-f) in Critical Care Patients with Acute Kidney Injury 
 
Background: Acute Kidney Injury (AKI) is common in Critical Care patient and cause 
significant increase mortality and morbidity. Early management of Renal Replacement Therapy 
with correct dose and suitable modality is an essential intervention in severe AKI. Hybrid 
therapy like Sustained Low Efficiency Daily Dialysis (SLEDD) has emerged as an alternative 
to CRRT in Intensive Care Unit (ICU) patients. Sustained Low Efficiency Daily Diafiltration 
(SLEDD-f), which contains both diffusion and convection principles, also suggested to 
provides stable renal replacement therapy. Thus, we formulated this study to compare the 
outcome between the administration of SLEDD and SLEDD-f in Critical Care patient with 
Acute Kidney Injury. 
   
Objectives: The objective of this randomized control trial is to compare the Intensive Care Unit 
(ICU) Survival between SLEDD and SLEDD-f in Critical Care patient with Acute Kidney 
Injury. The specific objective is to compare Length of Stay in ICU and Hospital, Days of 
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Ventilatory support, as well as control of acid base balance, small solute (urea and creatinine) 
and electrolytes (sodium and potassium) between SLEDD and SLEDD-f.   
 
Methods: Fourteen patient, with Acute Kidney Injury in Critical Care were selected with 
selection criteria were randomized into two group to received either Sustained Low Efficiency 
Daily Dialysis (SLEDD) or Sustained Low Efficiency Daily Diafiltration (SLEDD-f) for Renal 
Replacement Therapy. Selected parameters and blood investigation were recorded and 
compared including ICU predicted score, acid base status, renal function test, urine output and 
electrolytes are all taken during admission to hospital and critical care, before initiating the 
dialysis, day one after starting the dialysis until discharged from critical care and hospital, as 
well as during follow up until 42 days after dialysis. 3 month mortality also been recorded. 
 
Results: In both SLEDD and SLEDD-f group, the distributions of social-demographic, medical 
background status, as well as ICU predicted mortality like SOFA, SAPS II and APACHE II 
were similar. 85.7% of the AKI was due to sepsis while 14.3% due to multifactorial cause. 
Overall, there is no significant differences of outcome distribution (ICU and hospital survival, 
length of ICU and hospital stay; and duration of ventilatory support) and parameter distribution 
(urea, creatinine, sodium, pottasium and acid base balance) between patients receiving SLEDD 
and SLEDD-f technique (p>0.05). Mortality rate at day 60 reveals no significant difference in 
between both modalities with SLEDD having 42.9% mortality and SLEDD-f 14.3 % (p=0.554). 
In general, patients in SLEDD-f group have a shorter duration of ICU stay (median, 11 days 
[IQR 5 to 37 days]), duration of ventilation (median, 5 days [IQR 4 to 33 days]) and have a 
xix 
 
higher ICU survival (85.7%) compare to SLEDD group, but this was not statistically 
significant. Meanwhile, SLEDD have a shorter duration of hospital stay (median, 25 days [IQR 
16 to 29 days]) and this may result from higher mortality compare to SLEDD-f as the survivor 
may have prolonged length of stay at hospital.  
 
Conclusion: The administrations of SLEDD and SLEDD-f in ICU patients with AKI are 
feasible and comparable in terms of ICU survival, Length of ICU stay, Days of Ventilatory 
support as well as control of small solutes, electrolytes and acid base balance. Therefore, 
SLEDD-f can be used as an alternative therapy other than the conventional SLEDD with 
shorter duration of 4 hours as compared to SLEDD of 6 hours. 
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CHAPTER 1: INTRODUCTION 
 
Acute Kidney Injury (AKI) is a common clinical problem encountered in critically ill patient. It 
characteristically portends an increase in morbidity and mortality (Baghshaw et al. 2005). 
Despite technical advancement in the management of Acute Kidney Injury over the last 50 
years, critically ill patients with AKI remain to demonstrate high mortality rates. 
 
In the absence of any effective pharmacologic therapies of AKI, the management of AKI is 
remains supportive and prevention of the progression of the illness, focused on optimizing fluid 
balance, maintaining nutrition, treating electrolyte and acid base disturbances, adjusting the 
dose of medications excreted by the kidney, and avoiding secondary hemodynamic and 
nephrotoxic renal injury (Palevsky 2013). However early management of Renal replacement 
therapy is often considered as an essential intervention. 
 
RRT modalities have evolved over time, in parallel with technological advances, to offer better 
patient tolerability and solute removal. However ‗ideal‘ RRT setting remain controversial and 
delivery of standard RRT prescription is unlikely globally due to the high cost and need of 
specialized staff, which are unlikely to be sustainable in resource-limited settings (Jamal et al. 
2014).  Generally, the aims of treatment are to control fluid volume, correct acid-base 
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abnormalities, improve ureamia, promote renal recovery and improve mortality without causing 
complications (Oreilli et al. 2005).  Solute removal during RRT occurs by convection and/or 
diffusion. Conventional dialysis uses diffusion for solute removal, whereas haemofiltration 
techniques employ convection. In some instances, both diffusion and convection are combined, 
as in haemodiafiltration. 
 
Sustained Low Efficiency Daily Dialysis (SLEDD) has emerged as an alternative to CRRT in 
the management of hemodynamically unstable patient with AKI. In critically ill patients, the 
administration of SLEDD is feasible and provides comparable hemodynamic control and solute 
control to CRRT (Fieghen et al. 2010). Marshall et al 2004 also suggested that Sustained Low 
Efficiency Daily Diafiltration (SLEDD-f) provides stable renal replacement therapy with good 
clinical outcome with satisfactory logistic elements of SLEDD-f delivery by ICU nursing 
personnel. Therefore, both SLEDD and SLEDD-f have been considered as a viable alternative 
to CRRT in this setting.  
 
this development encourage us to compare the intensive care unit survival, days of ventilatory 
support, length of stay in ICU,  mortality and renal recovery; as well as acid base balance and 
solute control between SLEDD and SLEDD-f in critical care patient with acute kidney injury. 
At the moment, there is no similar prospective or retrospective study done on comparing 
SLEDD and SLEDD-f in critical care patients with AKI. 
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Thus the rationale of carrying out this pilot study is to compare SLEDD with SLEDD-f 
outcomes. With this comparison, SLEDD-f can be used as an alternative therapy other than the 
conventional SLEDD. SLEDD-f in this study focuses on a shorter duration of 4 hours as 
compared to SLEDD of 6 hours. With the additional diffusion SLEDD-f is seen to be able to 
clear larger molecules mainly in patients with sepsis however no studies have performed 
SLEDD-f in 4 hours. The main reason to shorten the time is with regards of the cost and 
hemodialysis nurse time conducting the dialysis session. 
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1.1 OBJECTIVES OF THE STUDY 
1.1.1  General Objectives 
The aim of this study is to compare the survival and mortality of the critical care patients with 
acute kidney injury receiving either Sustained Low Efficiency Daily Dialysis (SLEDD) or 
Sustained Low Efficiency Daily Diafiltration (SLEDD-f). 
 
1.1.2 Specific Objectives 
1. To compare ICU and hospital length of stay between SLEDD and SLEDD-f in critical care 
patients with acute kidney injury. 
2. To compare days of ventilatory support between SLEDD and SLEDD-f in critical care 
patients with acute kidney injury. 
3. To compare the control of small solutes and acid base balance between SLEDD and 
SLEDD-f in critical care patients with acute kidney injury. 
 
 
1.2 RESEARCH HYPOTHESIS 
There is no significant different in survival, mortality, length of stay, days of ventilatory 
support, the control of small solutes, electrolytes and acid base balance between SLEDD and 
SLEDD-f in critical care patients with Acute Kidney Injury. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1  ACUTE KIDNEY INJURY  
Acute kidney injury, previously known as acute renal failure. it is an abrupt and sustained 
decrease in renal function causing disturbances in fluid, electrolyte and acid base balance. 
Several experimental models have identified pathophysiologic mechanism associated with ARF 
(Lieberthal et al.2000). It is evident that ARF can result from alterations in renal perfusion, 
changes in glomerular filtration, and tubular dysfunction and that correction of these factors can 
ameliorate the effects of ARF (Heyman et al. 2002). Several new potential interventions have 
been developed showed to alter the course and established ARF in experimental model based 
on the identification of the underlying mechanism (Wang et al. 1997).  These resulted in 
improvement in the prevention of the ARF due to radiocontrast agent, aminoglycoside 
antibiotics and rhabdomyolysis (Block et al. 2002). In addition, there are advances in dialysis 
with the availability of Continuous Renal Replacement Therapies (CRRT), despite intermittent 
haemodialysis and acute peritoneal dialysis (Tonelli et al. 2002). 
 
Renal dysfunction is a complex syndrome including several different clinical pictures and 
etiologies (Ricci Z 2013). For this reason, the term Acute Kidney Injury (AKI) has been 
replaced the former expression ―Acute Renal Failure‖ and proposed a conventional definition 
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of acute changes in renal function. It is clear that renal dysfunction ranges from low level or 
risk of being injured, to an actual injury with reduced renal function, to a definitive failure with 
severely reduced or lost renal physiology. 
 
Figure 2.1 Conceptual Model of AKI (Adopted from National Review Nephrology 7) 
 
 
Figure 2.1 demonstrated the new conceptual model of AKI which incorporates changes in renal 
function and structure. It also illustrates the potential inverse relationship that may exist 
between changes in renal function as well as renal structure as captured by injury biomarkers. 
Risk incorporates both patient susceptibilities (for example, advanced age) as well as exposures 
(for example, sepsis). When susceptibilities are great, exposure may be limited but still result in 
AKI (Murugan et al. 2011).  
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2.2  DEFINITION AND CLASSIFICATION 
The Acute Dialysis Quality Initiative (ADQI) reported in 2002 that 35 definitions were used in 
medical literature of ARF, creating much confusion and making comparisons difficult 
(Bellomo 2004). Different authors have chosen different methods accessing renal function and 
different degrees of abnormality for diagnosis of ARF. Therefore, there were efforts to make a 
consensus definition and a level of similar classification to that achieved by two other common 
ICU syndromes; sepsis and acute respiratory distress syndromes (Kellum et al 2004).  This 
standardized case definition of ARF is necessary for comparisons of outcome across studies, 
development of prognostic systems, interpretation of therapeutic interventions and for design of 
multicenter studies. It also needs to classify the severity of the syndrome. 
 
There is a consensus definition of acute kidney injury by the Acute Dialysis Quality Initiative 
(ADQI). These RIFLE (risk, injury, failure, loss, end stage) criteria (Figure 2.1) have been 
broadly supported with minor modifications by the Acute Kidney Injury Network (AKIN) 
(Table 2.1) and both definitions have now been validated in thousands of patients and seem to 
work similarly to each other. A new consensus definition merging the RIFLE criteria and the 
AKIN definition has emerged from the Kidney Disease: Improving Global Outcomes (K-
DIGO) group (KDIGO 2012). 
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2.2.1 RIFLE Classification  
Through the persistent efforts of same group, with the advocacy to develop a consensus 
definition, ADQI published its consensus definition of ARF, using the set of criteria called 
RIFLE Classification in 2004 (Bellomo et al.2004) The acronym RIFLE stands for three 
increasing severity classes and two outcome class  
a. Risk of Renal Dysfunction (R) 
b. Injury to Kidney (I) 
c. Failure of Kidney Function (F) 
d. Loss of kidney Function (L) 
e. End Stage Kidney Disease (E)  
 
The three severity grades are defined based of a relatives increase in serum creatinine (sCr) or a 
period of decrease urine output, which is the worse. Glomerular Filtration Rate (GFR) is 
calculated as an increase of sCr above the baseline sCr level. When the baseline sCr is 
unknown and there is no past history  of Chronic Kidney Disease (CKD), sCr is calculated 
using the Modification of Diet in Renal Disease; formula for assessment of kiney function, 
assuming a GFR of 75ml/min/1.73m², as recommended by the ADQI workgroup (Figure 2.2) 
 
Estimated GFR = {75/[186 Х (age-0.23) X (0.742 if female) X (1.21 if black)]} – 0.887 
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By defining the syndrome of acute changes in renal function broadly, RIFLE Classification 
moved beyond ARF. Hence, after the meeting in Vicenza, Italy in September 2004, the ADQI 
group and representatives from three societies; American Society of Nephrology, International 
Society of Nephrology and National Kidney Foundation, and the European Society of Intensive 
Care, have proposed the term Acute Kidney Injury (AKI) as mentioned above, to reflect and 
encompass the entire spectrum of ARF, from minor changes in renal function to requirement 
for RRT recognizing that an acute decline in kidney function is often secondary to an injury 
that causes functional or structural changes in kidney. 
 
Figure 2.2 RIFLE Criteria for Acute Renal Dysfunction (Adopted from Crit Care 2004) 
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2.2.2  Acute Kidney Injury Network Classification (AKIN) 
Acute Kidney Injury Network (AKIN) is a proposed change to RIFLE Classification by an 
international multidisciplinary organization composed of nephrologist and intensivist. The 
diagnostic criteria according to AKIN are an abrupt reduction in kidney function within 48 
hour. The criteria include both an absolute and a percentage change in sCr to accommodate 
variation related to age, gender, and body mass index and to reduce the need for a baseline sCr 
but do require at least two sCr values within 48 hours. The urine output criterion was including 
based on the predictive importance of this measure but with the awareness that the urine output 
may not be measured routinely in unit of non-intensive care settings. It is assumed that the 
diagnosis based on the urine output criterion alone will require exclusion of urinary tract 
obstructions that reduce urine output or of other easily reversible causes of reduced urine 
output. It should be used in the context of the clinical presentation and following adequate fluid 
resuscitation when applicable. 
 
Table 2.1 Staging of AKI (KDIGO 2012) 
AKIN STAGE Urine output criteria 
1 Serum creatinine increases ≥ 26.5µmol/l (≥0.3 mg/dl) 
OR increase to 1.5-2.0 fold from baseline. 
<0.5 ml/kg/h for 6 hours 
2 Serum creatinine increase ≥2.0-3.0 fold from baseline. <0.5 ml/kg/h for 12 hours 
3 Serum creatinine increase > 3.0 fold from baseline OR 
serum creatinine ≥354 µmol/l (≥4.0 mg/dl) with an 
acute increase of at least 44 µmol/l (0.5 md/dl) OR need 
for RRT. 
<0.3 ml/kg/h for 24 hours 
OR anuria for 12 hours 
OR need for RRT 
 
11 
 
2.2.3  Comparison between RIFLE and AKIN Classification 
Both criteria were developed to facilitate clinical investigation and comparison across study 
populations. Baghshaw et al.2008 have demonstrated the epidemiology data comparing RIFLE 
and AKIN in critically ill patient (Table 2.2). The AKIN definition and classification 
incorporates sCr, urine output and time, no longer GFR compare to RIFLE classification. 
AKIN also reduce the need for baseline sCr but does require at least two sCr values within 48 
hours. AKIN also proposed that stages 1, 2 and 3 to be used instead of Risk, Injury and Failure; 
and the two outcome clsasses Loss and End-stage. Another important change from RIFLE 
classification  is patient will be categorized as stage 3 (failure) if they treated with RRT 
irrespective of what their sCr or urine output is at the point of initiation. However, the AKIN 
criteria could also improve the sensitivity of the AKI diagnosis but do not improve on the 
ability of the RIFLE criteria in predicting shot term outcome such as hospital mortality of 
critically ill ICU patients (Chang CH et al. 2010).  
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Table 2.2. A comparison of the RIFLE and AKIN Definition and Classification Schemes for 
AKI 
RIFLE category  Serum creatinine criteria UO criteria 
(A) The Acute Dialysis Quality Initiative (ADQI) criteria for the definition and classification of 
AKI (i.e. RIFLE criteria) 
Risk  Increase in serum creatinine ≥1.5X baseline 
or decrease in GFR ≥25% 
<0.5 mL/kg/h for ≥6 h 
Injury  Increase in serum creatinine ≥2.0X baseline 
or decrease in GFR ≥50% 
<0.5 mL/kg/h for ≥12 h 
Failure  
 
 
Increase in serum creatinine ≥3.0X baseline 
or decrease in GFR ≥75% or an 
absolute serum creatinine ≥354 μmol/L with 
an acute rise of at least 44 μmol/L 
<0.3 mL/kg/h ≥24 h or 
anuria ≥12 h 
   
AKIN category  Serum creatinine criteria UO criteria 
(B) The proposed Acute Kidney Injury Network (AKIN) criteria for the definition and 
classification of AKI 
Stage 1  Increase in serum creatinine ≥26.2 μmol/L 
or increase to ≥150–199% (1.5- to 
1.9-fold) from baseline 
<0.5 mL/kg/h for ≥6 h 
Stage 2 Increase in serum creatinine to 200–299% 
(>2–2.9 fold) from baseline  
<0.5 mL/kg/h for ≥12 h 
Stage 3 Increase in serum creatinine to ≥300% (≥3-
fold) from baseline or serum 
creatinine ≥354 μmol/L with an acute rise of 
at least 44 μmol/L or initiation of 
RRT 
<0.3 mL/kg/h ≥24 h or 
anuria ≥12 h 
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2.3  ACUTE KIDNEY INJURY IN CRITICAL CARE  
The incidence of AKI is increasing, with mortality associated with AKI remains unacceptably 
high. Increasing severity correlates with increasing mortality. A systematic review of 312 
cohort studies which include 49 million patients found that AKI occurred in one in five adults 
and one in three children hospitalized with acute illness (Rewa & Baghshaw 2014). In large 
retrospective cohort studies (n=49518), 1% of hospitalized patients had evidence of subacute 
kidney injury, with a relative changes in serum creatinine fulfilling the RIFLE classification for 
AKI, which associated with increase hospital mortality.  
 
Several large cohort studies have focused on describing the incidence in intensive care settings 
(Andrikos et al. 2009, Baghshaw et al. 2007). The incidence of AKI among patients admitted to 
Intensive Care Unit (ICU) was 5.7%, in a large multinational study, using the definition of AKI 
as urine output <200ml in 12 hour; serum urea >30mmol/l or initiation of RRT. Subsequent 
cohort studies that integrated consensus definition of AKI and used administrative databases 
reported AKI incidence in ICU setting is 16%-39%  (Baghshaw et al 2008, Ostermann et al. 
2007). The marked increase incidence in these studies is likely attributable to application of 
consensus AKI criteria as intended, with inclusion of urine output criteria. Malaysian Registry 
of Intensive Care Report 2013 reported that incidence of AKI within 24 h of ICU admissionis 
approximately 14%, with 15% of all critically ill patients receiving RRT at some point. 
Approximately half of the patients that develop AKI (49.3%) receive RRT. AKI was 
associatedwith an in-hospital mortality rate of 41.4%, and is encountered in up to 80% of 
patients presenting with severe sepsis and multi-organ failure (Tong et al. 2013).  
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Figure 2.3 Risk of AKI Varies by Definition Used and Timing of Assessment (Adopted from 
National Review of Nephrology) 
 
Figure 2.3 showed the relationship between application of RIFLE criteria and the apparent 
incidence of AKI varies according to the definition used and the time at which it is applied, 
which can lead to underestimations in the incidence of AKI.   
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2.4  RISK FACTOR FOR AKI 
A wide variety of risk factor have been described for the development of AKI in the ICU but 
there is no clear understanding of what risk factors confer the highest risk for the development 
of AKI despite assessment and studies in diverse populations. Impact and the association of 
those risk factors need a better understanding for designing predictive models of high risk 
patients and to create preventative strategies that might benefit patient from developing lethal 
condition. Kolhe et al 2008 has showed that there is lack of meaningful predictive models in 
mixed and medical ICU where most of the prediction models have focused on the impact on 
mortality of AKI in ICU patients.   
  
The causes of AKI in ICU patients is commonly represent multifactorial etiologies, both patient 
and procedure related. Patient related factors such as increasing age, hypertension, diabetes 
mellitus, cardiac failure, peripheral vascular disease, cerebrovascular disease and preexisting 
CKD; are often more strongly associated with postoperative mortality than procedure related 
factors. Whereby high risk procedure or operation such as cardiopulmonary bypass, emergency 
surgeries, prolonged surgical period; will serve as a predisposing factor for AKI 
postoperatively. (Liano et al 1998) 
 
There are several ways to classify the risk factor for AKI. Caused of AKI are also frequently 
categorized as pre-renal, intrinsic renal and post renal. However, this can oversimplifies the 
overlapping pathologic mechanism underlying AKI. Baghshaw et al 2014 classified the risk 
factor into non modifiable and potentially modifiable risk factor as described in table 2.3 
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Table 2.3  Risk Factors for AKI 
Non-modifiable Potentially modifiable 
 
■Old age 
■Male sex 
■Black race 
■Pre-existing chronic kidney disease 
■Proteinuria or elevated albumin-to-creatinine 
ratio 
■Hypertension 
■Diabetes mellitus 
■Chronic liver disease and/or complications 
of portal hypertension 
■Heart failure and/or decreased ejection 
fraction 
■Coronary artery disease and/or recent 
myocardial infarction 
■Chronic obstructive pulmonary disease 
■Peripheral vascular disease 
■Malignancy 
 
 
■Anaemia 
■Critical illness 
■Sepsis 
■Trauma 
■Cardiac surgery 
■Major noncardiac surgery 
■Exposure to radiocontrast media 
■Fluid overload 
■Fluid resuscitation with synthetic colloids 
(hydroxyethyl starch) or chloride rich 
solutions (0.9% saline) 
■Drug toxicity, drug interactions or 
nephrotoxic medications 
■High-risk or emergency procedures 
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2.4.1  Extreme of Age  
Elderly and very young patients are particularly susceptible to AKI. Hospitalised children are at 
increased risk up to 50% of acutely ill children developed AKI; most commonly in association 
with major surgery with or without sepsis.  Although older age has consistently been shown to 
increase the risk of AKI (Coca et al 2011), elderly patients with AKI are far less likely to 
receive RRT than are younger patients. GFR is thought to decrease by 1% per year over the age 
of 20 years due to a progressive loss of renal cortical glomeruli. There is a 50% decrease in the 
tubular function ageing, with reduced renal concentrating ability and free water clearance. An 
observational study suggested that critically ill patient with AKI are increasingly older, due to 
the physiologic ageing of the kidneys, impaired renal recoverability, multiple comorbidities, ere 
more probably septic and have greater severity of illness and organ failure.  
 
2.4.2  Proteinuria 
Preexisting proteinuria is a risk factor for the development of AKI among hospitalized patients. 
In patient with proteinuria and eGFR more than 60ml/min/1.73m², the adjusted risk of AKI was 
4.4 fold higher than in those with no proteinuria (James 2010). A similar increased of risk of 
AKI associated with elevated urine albumin to creatinine ratio was further increase by 
declining eGFR. In a large cohort of patients undergoing cardiac surgery, increased urine 
albumin to creatinine ratio independently predicted post-operative AKI and improved clinical 
risk prediction. It also associated with increased dialysis risk, mortality and prolonged ICU and 
hospital stay.  
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2.4.3  Comorbid disease 
Overt CKD is an independent risk factor for development of AKI, non-recovery of renal 
function and progression to End Stage Renal Disease (ESRD). It also a recognized risk factor 
for development for death, cardiovascular events and hospitalization. Evidence by its 
integration into numerous clinical practice guidelines and risk prediction score for development 
of post procedural and need for RRT, CKD is one of strongest predictors to AKI. 
In addition, non-renal comorbid diseases also modify the risk of AKI such as Diabetes Mellitus, 
hypertension, cardiovascular disease, peripheral vascular disease, chronic liver disease and 
chronic obstructive pulmonary disease. Comorbidities reportedly set the backstage of the 
subsequent renal injury, through the interplay of disrupted renal autoregulation, pre-existing 
renal damage and concomitant use of nephrotoxic medication (Leung et al 2012). 
 
2.4.4  Sepsis 
Sepsis or Systemic Inflammatory Response Syndrome (SIRS) by means of its glomerular 
hemodynamic alterations, induction of reactive oxygen species and oxidative stresses, and 
tubular ischemic injury can contributes to AKI development. The toxic effect of sepsis on AKI 
do not appear to be specific to bacterial or pathogen; as H1N1 influenza pandemic in 2009 
demonstrated that viral infections caused significant rates up to 51% ( Martin et al 2011). 
Sepsis is known precipitating factor of AKI and the development of AKI, as well as it will 
further predispose the episode of sepsis. AKI occurs most commonly in association with sepsis 
and marked increase in risk of adverse outcome in ICU. A multicenter cohort study (Baghshaw 
et al 2009) found that 64.4% of critically ill patients with septic shock developed AKI within 
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24 hour of ICU admission. Delay in administration of appropriate antimicrobial therapy after 
the onset of hypotension was associated with increased risk of AKI. Higher RRT use and risk 
of death has been reported in patients with sepsis occurring after AKI compared with patient 
without sepsis (Mehta et al 2011).  
 
Furthermore, current sepsis resuscitation guidelines advocate aggressive volume resuscitation 
for patient presenting with severe sepsis in an effort to improve overall survival according to 
Spoelstra De Man 2008. However, the Sepsis Occurrence in Acutely Ill (SOAP) trial 
demonstrated an increased AKI developing within the first 48 hour of ICU admission in those 
patients with a fluid balance (Vincent et al 2006). A post hoc analysis revealed that the early 
and aggressive volume resuscitation can improved outcomes, but patient with more fluid 
balance subsequently developed AKI (Dellinger 2008). It suggest the benefits of fluid 
administration may be time sensitive (Payen et al 2008). 
 
2.4.5  Trauma 
AKI occurs in trauma patient up to 31% (Vivino et al 1998). It is due to multifactorial causes 
such as hemorrhagic shock, abdominal compartment syndrome and rhabdomyolysis. 
Rhabdomyolysis accounts 28 of trauma associated AKI requiring dialysis (Sharp et al 2004). 
Abdominal compartment pressure more than 12mmHg is associated with AKI as kidney are an 
early sensors of intrabdominal hypertension. Therefore a sustained increased in intra-abdominal 
pressure more than 20mmHg in association with new organ dysfuntion will be associated with 
AKI in 30% of cases (Cheatham et al 2007 and De laet et al 2007). 
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2.4.6  Fluid Resuscitation and Overload. 
In particular in patient with sepsis, randomized trial of fluid resuscitation using the synthetic 
colloid hydroxyethyl starch compared to crystalloid have shown higher risk of AKI and RRT 
use (Myburgh et al 2012 and Perner et al 2012). Administration of chloride rich solution 
compared to balanced crystalloid also associated with increased risk of AKI and RRT use 
(Yunos et al 2012) due to chloride loading that might result in deleterious changes in renal 
hemodynamics and contributes to excess fluid retention.  Fluid overload is increasingly 
associated with AKI Grams et al 2011) as well as increased mortality. Numerous mechanisms 
might contribute to the adverse renal consequences of fluid overload including increased 
systemic venous pressure, renal specific parenchymal edema, intra-abdominal hypertension, 
and the physiological effect of intervention to treat fluid overload such as diuretic therapy and 
mechanical ventilation.   
 
2.4.7  Hypotension 
Baghshaw et al 2009 studied the relationship of hypotension and AKI or mortality focused on 
septic shock patient. It reported that the severity and duration of hypotension are bith 
significant risk factor of AKI development in ICU patient. Odds of AKI increase by 3% in 
every 1mmHg decrease in mean arterial pressure (MAP) below 80mmHg. As the degree of 
hypotension worsened, the increased risk of AKI from each additional hour of continuous 
hypotension more than double for each 10mmHg drop in MAP below 80mHg (Li Wei et al 
2010). Brienza et al 2009 also demonstrated that 80% of patient with post-operative AKI 
having an episode of haemodynamic instability in the peri-operative period. 
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2.4.8  Major and High Risk Surgery 
Both cardiac surgery and major non-cardiac surgeries is associated with increased risk of AKI; 
as its incidence is modified by the burden of baseline susceptibilities and perioperative factors. 
Perioperative risk factors included older age, higher BMI, comorbid disease and high risk or 
emergency surgeries.  
 
The incidence of AKI in hospitalized patient ranges from 18% to 47% depending on definition 
used (Carmichael et al. 2003). Several high risk procedures or surgeries such as cardiac 
surgeries with CPB, combined valve and coronary artery bypass grafting (CABG)surgery, 
emergent surgeries, increased intra-abdominal pressure in major abdominal surgery or lengthy 
surgery period, serve as predisposing factor for AKI after operation (Loef et al. 2005). These 
are associated with either poor renal perfusion or decrease renal reserve. The BEST Kidney 
(beginning and ending supportive therapy for the kidney) trial confirmed that the major surgery 
is the second leading cause of AKI (34%) in the critically ill patients in the intensive care 
settings with overall mortality of 60.3% (Uchino et al. 2005). United Kingdom Intensive Care 
National Audit and Research Centre Case Mix program showed the surgical admissions 
accounted for 16.4% admissions with severe AKI in the first 24 hours. It was respectively 
accounted by 5.6% elective and 10.8% emergency cases.    
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2.4.9  Cardiac and Vascular Surgery 
The estimated incidence of AKI in patients undergoing cardiac surgery is between 11% to 30%; 
which was designed using RIFLE and KDIGO criteria or as a 50% increase in serum 
creatinine(Ho J et al.2012 and Bastin et al. 2013). Severe AKI requiring RRT occurs in an 
estimated 1% to 2% of these patients. Several studies have examined the risk factors associated 
with the development of AKI after Cardiopulmonary bypass (CPB) surgery, with valvular 
procedure associated with a higher risk. Typical CABG has the lowest incidence of AKI 
approximately 2.5% and dialysis dependent approximately 1%, followed by valvular surgery 
with an incidence of AKI of 2.8% dialysis dependent of 1.7%. The highest risk group includes 
combined coronary artery and valvular surgery with an incidence of AKI of 4.6% and dialysis 
dependent of 3.3% (Abraham et al. 2005 and Grayson et al. 2003). 
 
Certain risk factors have been repeatedly associated with an increased risk of AKI, in almost all 
studies, including female gender, reduced left ventricular function or the presence of congestive 
heart failure, diabetes, peripheral vascular disease, preoperative use of an intra-aortic balloon 
pump, chronic obstructive pulmonary disease, the need for emergent surgery and an elevated 
preoperative sCr. Almost all of the defined risk factors related to either impaired renal 
perfusion or decreased renal reserve.The strongest predictors of post-operative AKI among 
clinical risk scores are baseline kidney function and KD status. Patients with decreases in 
serum creatinine level from baseline immediately after surgery were less likely to develop AKI 
compared to those whose serum creatinine level increased after surgery. 
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Table 2.4 Risk Factor Associated with AKI in Cardiac Surgery 
Patient Related Factors Procedure Factors 
 Female Gender 
 Chronic Obstructive Pulmonary Disease 
 Diabetes Mellitus 
 Chronic Kidney Disease 
 Peripheral Vascular Disease 
 Congestive Cardiac Failure 
 Left Ventricular Failure (EF< 35%) 
 Cardiogenic Shock with use of IABP 
 Left Main Coronary Disease 
 Emergency Surgery 
 Length of CPB 
 Aortic Cross Clamp Time 
 On pump CABG 
 Non-pulsatile flow 
 Haemodilution 
 Haemolysis 
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2.4.10  Exposure to Nephrotoxins 
Population based studies have shown an increased risk of hospitalization-requiring AKI up to 
20% of all cases of AKI in ICU following initiation or exposure to commonly prescribed 
medication including high potency statins, proton pump inhibitors, non-steroidal inflammatory 
drugs, fluoroquinolones, fibrates and highly active anti-retroviral therapies (Uchino et al. 
2005). The mechanism of medication induced AKI is variable and includes direct tubular 
toxicity, acute interstitial nephritis and haemodynamics perturbations. 
 
Similarly AKI is increasingly associated with adverse drug interactions, toxicity, inappropriate 
prescriptions, failure of clinician to adjust for kidney function when calculating dosages in at 
risk patients and continued exposure to nephrotoxins during AKI. Worsening AKI and 
hypotension is the most common, potentially avoidable, adverse drug reactions, with 
angiotensin-converting-enzyme inhibitors and antithrombotics commonly implicated. 
Hospitalized patients, particularly those in ICUs, are often exposed to multiple concurrent 
nephrotoxins. Antimicrobials are common sources of avoidable nephrotoxicity and exposure to 
contrast media is also frequently associated with AKI in hospitalized patients (Nash K et al. 
2002). 
  
